Correlation Between Bone Biologics and ReShape Lifesciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bone Biologics and ReShape Lifesciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bone Biologics and ReShape Lifesciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bone Biologics Corp and ReShape Lifesciences, you can compare the effects of market volatilities on Bone Biologics and ReShape Lifesciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bone Biologics with a short position of ReShape Lifesciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bone Biologics and ReShape Lifesciences.

Diversification Opportunities for Bone Biologics and ReShape Lifesciences

-0.23
  Correlation Coefficient

Very good diversification

The 3 months correlation between Bone and ReShape is -0.23. Overlapping area represents the amount of risk that can be diversified away by holding Bone Biologics Corp and ReShape Lifesciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ReShape Lifesciences and Bone Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bone Biologics Corp are associated (or correlated) with ReShape Lifesciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ReShape Lifesciences has no effect on the direction of Bone Biologics i.e., Bone Biologics and ReShape Lifesciences go up and down completely randomly.

Pair Corralation between Bone Biologics and ReShape Lifesciences

Given the investment horizon of 90 days Bone Biologics Corp is expected to under-perform the ReShape Lifesciences. In addition to that, Bone Biologics is 1.39 times more volatile than ReShape Lifesciences. It trades about -0.16 of its total potential returns per unit of risk. ReShape Lifesciences is currently generating about 0.01 per unit of volatility. If you would invest  574.00  in ReShape Lifesciences on August 28, 2024 and sell it today you would lose (6.00) from holding ReShape Lifesciences or give up 1.05% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Bone Biologics Corp  vs.  ReShape Lifesciences

 Performance 
       Timeline  
Bone Biologics Corp 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Bone Biologics Corp are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak essential indicators, Bone Biologics reported solid returns over the last few months and may actually be approaching a breakup point.
ReShape Lifesciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ReShape Lifesciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's essential indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Bone Biologics and ReShape Lifesciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bone Biologics and ReShape Lifesciences

The main advantage of trading using opposite Bone Biologics and ReShape Lifesciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bone Biologics position performs unexpectedly, ReShape Lifesciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ReShape Lifesciences will offset losses from the drop in ReShape Lifesciences' long position.
The idea behind Bone Biologics Corp and ReShape Lifesciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Other Complementary Tools

Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world